No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CYTO Altamira Therapeutics
- 1.1502
- -0.0998-7.98%
Trading Jun 20 12:42 ET
2.58MMarket Cap-129P/E (TTM)
1.2799High1.1500Low93.59KVolume1.2500Open1.2500Pre Close113.28KTurnover4.22%Turnover RatioLossP/E (Static)2.24MShares17.200052wk High0.35P/B2.55MFloat Cap1.150052wk Low--Dividend TTM2.22MShs Float636800.0000Historical High--Div YieldTTM10.39%Amplitude1.1500Historical Low1.2100Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Altamira Therapeutics Highlights Review Article Published On Use Of Betahistine In Vertigo Management
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedur
Express News | Altamira Therapeutics Ltd - Merged Entity Will Be Called Altamira Therapeutics AG and Continue to Serve as Core Operating Subsidiary of Company
Express News | Altamira Therapeutics Provides Business Update On RNA Delivery Platform; Announces Improvement In RNA Nanoparticle Stability, Pursues Partnering Opportunities For AM-125 In Vertigo And CNS Indications, And Switches Financial Reporting From Swiss...
Express News | Altamira Therapeutics Ltd - Co Is About to Merge Two of Its Subsidiaries in Basel (Switzerland), Auris Medical AG and Altamira Therapeutics AG
Express News | Altamira Therapeutics Ltd - Streamlining Corporate Structure; Switch in Financial Reporting From Swiss Francs to US Dollars
Comments
$Altamira Therapeutics(CYTO.US$
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Altamira Therapeutics, under the stock ticker CYTO, has highlighted a newly published review supporting the use of betahistine for managing residual dizziness in benign paroxysmal positional vertigo (BPPV) patients. The review, appearing in Frontiers in Neurology, suggests that betahistine, which is commonly used outside the US, can significantl...
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Altamira Therapeutics, under the stock ticker CYTO, has highlighted a newly published review supporting the use of betahistine for managing residual dizziness in benign paroxysmal positional vertigo (BPPV) patients. The review, appearing in Frontiers in Neurology, suggests that betahistine, which is commonly used outside the US, can significantl...
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal.
Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company focused on developing and commercializing RNA delivery technology for targets beyond the liver, recently announced the dissemination of positive results from its NASAR clinical trial with Bentri...
Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company focused on developing and commercializing RNA delivery technology for targets beyond the liver, recently announced the dissemination of positive results from its NASAR clinical trial with Bentri...
$Altamira Therapeutics(CYTO.US$ I'm in let's go
1
$Altamira Therapeutics(CYTO.US$
NEWS
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
NEWS
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg